Second Hospital of Hebei Medical University, 215 Hepingxi Road, Shijiazhuang City, Hebei Province, 050000, China; Hebei Provincial Center for Clinical Laboratories, 215 Hepingxi Road, Shijiazhuang City, Hebei Province, 050000, China.
Second Hospital of Hebei Medical University, 215 Hepingxi Road, Shijiazhuang City, Hebei Province, 050000, China; Hebei Provincial Center for Clinical Laboratories, 215 Hepingxi Road, Shijiazhuang City, Hebei Province, 050000, China.
Anaerobe. 2022 Jun;75:102585. doi: 10.1016/j.anaerobe.2022.102585. Epub 2022 May 8.
Clostridioides difficile is a Gram-positive, obligate anaerobic, spore-producing intestinal opportunistic pathogen. CDI outbreaks in Europe and the Americas in recent years are a major health concern. Intestinal short-chain fatty acids (SCFAs) are an important energy source for colonic epithelial cells, and the roles of SCFAs in reducing intestinal inflammation, inhibiting intestinal tumors, and regulating gut microbial homeostasis are being actively researched. Furthermore, SCFAs attenuate CDI or directly inhibit C. difficile growth through different pathways in vivo and in vitro. This review assesses the role of SCFAs in CDI and discusses the potential use of these molecules as therapeutic targets for CDI.
艰难梭菌是一种革兰阳性、专性厌氧、产芽孢的肠道机会致病菌。近年来,艰难梭菌在欧洲和美洲的爆发是一个主要的健康关注点。肠道短链脂肪酸(SCFAs)是结肠上皮细胞的重要能量来源,SCFAs 在减轻肠道炎症、抑制肠道肿瘤和调节肠道微生物群平衡方面的作用正在被积极研究。此外,SCFAs 通过体内和体外的不同途径减轻艰难梭菌感染或直接抑制艰难梭菌的生长。本综述评估了 SCFAs 在艰难梭菌感染中的作用,并讨论了这些分子作为艰难梭菌感染治疗靶点的潜在用途。